De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway
- 17 December 2010
- journal article
- Published by Wiley in Histopathology
- Vol. 57 (6) , 836-850
Abstract
Fritsche‐Guenther R, Noske A, Ungethüm U, Kuban R‐J, Schlag PM, Tunn P‐U, Karle J, Krenn V, Dietel M & Sers C (2010) Histopathology57, 836–850 De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway Aims: In osteosarcoma patients the development of metastases, often to the lungs, is the most frequent cause of death. The aim of this study was to elucidate the molecular mechanisms governing osteosarcoma development and dissemination and, thereby, to identify possible novel drug targets for improved treatment.Methods and results: Osteosarcoma samples were characterized using genome‐wide microarrays: increased expression of the EphA2 receptor and its ligand EFNA1 was detected. In addition, increased expression of EFNB1, EFNB3 and EphA3 was suggested. Immunohistochemistry revealed an absence of EphA2 in normal bone, and de novo expression in osteosarcomas. EFNA1 was expressed in normal bone, but was significantly elevated in tumours. Further in vitro investigations on the functional role of EphA2 and EFNA1 showed that EFNA1 ligand binding induced increased tyrosine phoshorylation, receptor degradation and downstream mitogen‐activated protein kinase (MAPK) activation. Interference with the MAPK pathway unravelled a potential autoregulatory loop governing mainly EFNA1 expression via the same pathway.Conclusion: Upregulation and de novo expression of ephrins in osteosarcomas are involved in oncogenic signalling and thus might stimulate osteosarcoma metastasis.Keywords
This publication has 31 references indexed in Scilit:
- Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survivalBritish Journal of Cancer, 2009
- EphA2 Reexpression Prompts Invasion of Melanoma Cells Shifting from Mesenchymal to Amoeboid-like Motility StyleCancer Research, 2009
- Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasisLaboratory Investigation, 2009
- Giant cell tumors of the bone: Molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFRPathology - Research and Practice, 2005
- The role of ephrins and Eph receptors in cancerCytokine & Growth Factor Reviews, 2004
- Human osteosarcoma expresses specific ephrin profilesCancer, 2002
- Common Musculoskeletal Tumors of Childhood and AdolescenceNew England Journal of Medicine, 1999
- Bone and Soft Tissue Tumors1999
- Growth and development and other risk factors for osteosarcoma in children and young adultsInternational Journal of Epidemiology, 1997
- The therapy of osteogenic sarcoma: Current status and thoughts for the futureJournal of Surgical Oncology, 1972